Drug profile · INN
dichlorphenamide
ORMALVI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dichlorphenamide (ORMALVI) is an FDA-listed pharmaceutical active ingredient. Associated with Xeris Biopharma Holdings. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dichlorphenamide
Brand ORMALVI
Route ORAL
Formulation TABLET
Originator Xeris Biopharma Holdings
Frequently asked questions
What is dichlorphenamide?
dichlorphenamide (ORMALVI) is an FDA-listed pharmaceutical active ingredient. Associated with Xeris Biopharma Holdings. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dichlorphenamide?
ORMALVI is a marketed brand name for dichlorphenamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dichlorphenamide?
dichlorphenamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.